Tilray, Inc. (TLRY)
Stock Price: $6.96 USD
-0.05 (-0.71%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Stock Price Chart
Key Info
| Market Cap | 869.04M |
| Revenue (ttm) | 179.49M |
| Net Income (ttm) | -474.99M |
| Shares Out | 108.20M |
| EPS (ttm) | -4.61 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Jul 2, 2020 |
| Last Price | $6.96 |
| Previous Close | $7.01 |
| Change ($) | -0.05 |
| Change (%) | -0.71% |
| Day's Open | 7.15 |
| Day's Range | 6.89 - 7.28 |
| Day's Volume | 4,180,478 |
| 52-Week Range | 2.43 - 49.49 |
More Stats
| Market Cap | 869.04M |
| Enterprise Value | 1.17B |
| Earnings Date (est) | Sep 1, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 108.20M |
| Float | 82.45M |
| EPS (basic) | -4.61 |
| EPS (diluted) | -4.61 |
| FCF / Share | -3.41 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 19.51M |
| Short Ratio | 1.32 |
| Short % of Float | 18.23% |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 4.84 |
| PB Ratio | 5.62 |
| Revenue | 179.49M |
| Operating Income | -341.29M |
| Net Income | -474.99M |
| Free Cash Flow | -363.03M |
| Net Cash | -302.65M |
| Net Cash / Share | -2.42 |
| Gross Margin | -11.95% |
| Operating Margin | -190.14% |
| Profit Margin | -242.30% |
| FCF Margin | -202.25% |
| ROA | -13.92% |
| ROE | -166.34% |
| ROIC | -63.20% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Consensus: Overweight
*Average 12-month price target from 12 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|
| Revenue | 167 | 43.13 | 20.54 | 12.64 |
| Revenue Growth | 287.15% | 110% | 62.43% | - |
| Gross Profit | -23.50 | 14.28 | 11.38 | 2.67 |
| Operating Income | -300 | -57.84 | -7.50 | -7.05 |
| Net Income | -321 | -67.72 | -7.81 | -7.88 |
| Shares Outstanding | 100 | 83.01 | 75.00 | 75.00 |
| Earnings Per Share | -3.20 | -0.82 | -0.10 | -0.11 |
| Operating Cash Flow | -258 | -46.25 | -6.00 | -3.32 |
| Capital Expenditures | -67.16 | -49.49 | -10.89 | -0.49 |
| Free Cash Flow | -325 | -95.73 | -16.89 | -3.81 |
| Cash & Equivalents | 96.79 | 518 | 2.32 | 7.53 |
| Total Debt | 430 | 429 | 51.22 | 28.70 |
| Net Cash / Debt | -333 | 88.47 | -48.89 | -21.17 |
| Assets | 896 | 657 | 53.95 | 33.09 |
| Liabilities | 611 | 459 | 58.80 | 30.57 |
| Book Value | 285 | 198 | -4.85 | 2.53 |
Numbers in millions USD, except per-share numbers.
Company Profile
Company Details
| Full Name | Tilray, Inc. |
| Country | Canada |
| Employees | 1,646 |
| CEO | Brendan Kennedy |
Stock Information
| Ticker Symbol | TLRY |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Unique Identifier | NASDAQ: TLRY |
| IPO Date | July 19, 2018 |
Description
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, and compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, the United Kingdom, the United States, and South Africa. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.